Clinical trial
High-Dose Quinapril Versus Low-Dose Quinapril Plus Amlodipine in the Treatment…
NCT00313547 · Montreal Heart Institute, Other · Terminated
Key facts
| NCT number | NCT00313547 |
|---|---|
| Title | High-Dose Quinapril Versus Low-Dose Quinapril Plus Amlodipine in the Treatment of High-Risk Hypertensive Patients |
| Official title | Impact of High-Dose Quinapril Versus Low-Dose Quinapril Plus Amlodipine on Autonomic Regulation and on Sympathetic Activation in Response to Cold Exposure in Hypertensive Patients With Impaired Glucose Tolerance, Diabetes or Coronary Artery Disease |
| Lead sponsor | Montreal Heart Institute, Other |
| Collaborators | Pfizer Industry |
| Status | Terminated |
| Phase | Phase 4 |
| Study type | Interventional |
| Conditions | Hypertension |
| Intervention type | Drug |
| Interventions | Quinapril 40 mg, Quinapril 10 mg and amlodipine 5 mg |
| Enrollment | 40 |
| Start date | Apr 1, 2006 |
| Primary completion | Apr 1, 2007 |
| Completion | Mar 1, 2008 |
| First posted | Apr 12, 2006 |
| Last update posted | May 6, 2008 |
| Countries | Canada |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: